Cellebrite DI (NASDAQ:CLBT) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Cellebrite DI (NASDAQ:CLBT) released its earnings results on Thursday. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.03), Zacks reports. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. Cellebrite DI updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

Cellebrite DI Price Performance

Shares of NASDAQ CLBT traded down $2.68 during midday trading on Thursday, reaching $22.24. 2,603,509 shares of the stock traded hands, compared to its average volume of 1,806,094. The stock has a market capitalization of $4.58 billion, a PE ratio of -14.41, a P/E/G ratio of 3.72 and a beta of 1.47. Cellebrite DI has a one year low of $9.22 and a one year high of $26.30. The company’s 50 day moving average is $22.57 and its 200 day moving average is $19.09.

Analyst Ratings Changes

CLBT has been the subject of several analyst reports. Needham & Company LLC increased their target price on shares of Cellebrite DI from $21.00 to $28.00 and gave the stock a “buy” rating in a report on Wednesday, January 22nd. JPMorgan Chase & Co. upped their price target on Cellebrite DI from $24.00 to $28.00 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, Craig Hallum upped their price target on Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. Eight research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $22.14.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.